Profil Financier
Sun Piaoyang occupe actuellement le rang #328 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $10.8 B (+$206 sur 24h).
Sun Piaoyang is the chairman of Jiangsu Hengrui Pharmaceuticals. He has turned a formerly state-led business into one of China's largest producers of anti-infection and tumor-treating medicines.
He became the head of the state-led company in 1990 when he was 32 years old.
After taking Hengrui public in Shanghai in 2000, Sun led the firm to complete a Hong Kong listing in 2025, raising $1.3 billion.
Sun's wife Zhong Huijuan, also a billionaire, is the chairman and CEO of Hansoh Pharmaceutical Group, a drug maker that listed on the Hong Kong Stock Exchange in 2019.
Their daughter, Sun Yuan, is Hansoh's executive director.